Stay Updated
Press Releases
WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed an amicus brief in the U.S. Court of Appeals for the Third Circuit, defending Medicare’s ability to negotiate lower drug prices against a lawsuit brought by pharmaceutical giant Novartis. The lawsuit is part of a broader industry-wide legal assault aimed at dismantling the 2022 prescription drug law’s historic […]
Press Releases
WASHINGTON, D.C. — Following a narrow Senate vote, Robert F. Kennedy Jr., was confirmed today as Secretary of the Department of Health and Human Services (HHS). P4AD Executive Director, Merith Basey, released the following statement: “Secretary Kennedy has a critical opportunity – and responsibility – to build on existing measures to rein in Big Pharma’s price-gouging and lower drug […]
Press Releases
RELEASE: New Report Exposes PhRMA’s Misinformation Campaign To Undermine 2022 Prescription Drug Law
WASHINGTON, D.C. — A new report from Patients For Affordable Drugs reveals that the Pharmaceutical Research and Manufacturers of America (PhRMA) and its allies have spent heavily on advertisements – based on misleading and at times blatantly false claims – designed to undermine the 2022 prescription drug law – a law that is already lowering drug prices and […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs welcomes the Centers for Medicare & Medicaid Services (CMS) statement today reaffirming the continuation of Medicare drug price negotiation. P4AD Founder and President, David Mitchell, released the following statement in response: “We are very pleased to see the Medicare prescription drug program move forward under the Trump Administration. […]
Press Releases
P4AD Pushes Back On Pharmaceutical Company Claims, Highlights The Drug Industry’s Decades-Long Prohibition On Medicare’s Ability To Negotiate Lower Drug Prices, And Amplifies The Experiences Of Patients WASHINGTON, D.C. — Patients For Affordable Drugs filed a 29-page amicus brief today in the U.S. Court of Appeals in the Second Circuit, defending the Medicare negotiation program […]
Press Releases
Patients For Affordable Drugs Celebrates Another Critical Step Forward in the Fight Against Skyrocketing Prescription Costs WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has the 2024 milestone, when prices were successfully negotiated for the first 10 drugs under the 2022 prescription drug law, this expansion marks another major step toward ensuring […]
Press Releases
This Marks The 10th Lawsuit Filed By Pharma And Its Allies To Undermine Medicare Drug Price Negotiation At the Expense Of Patients WASHINGTON, D.C. — On the verge of the announcement of the next 15 drugs selected for Medicare drug price negotiations, Teva Pharmaceuticals filed a lawsuit in the U.S. District Court for the District […]
Press Releases
ICYMI: Patients On Medicare Celebrate $2,000 Cap On Out-Of-Pocket Costs
Millions Of Patients Anticipate Substantial Savings As New Limit On Annual Out-of-Pocket Costs Goes Into Effect January 1st WASHINGTON, D.C. — Starting this week, everyone with Medicare Part D will have their annual out-of-pocket drug costscappedat $2,000. This historic reform is one of the most substantial provisions from the 2022 prescription drug price law to […]